Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Volunteers (Part 1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05930782
What this trial is testing

Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers.

Who this might be right for
Malaria
Medicines for Malaria Venture 60
Early research (Phase 1)Ended earlyNCT02120976
What this trial is testing

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252

Who this might be right for
Diabetes Mellitus
Akros Pharma Inc. 85
Early research (Phase 1)Study completedNCT02269735
What this trial is testing

A Three-part Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-2640 in Healthy Participants (Part I) and Participants With Type 1 Diabetes Mellitus (Parts II and III) (MK-2640-001)

Who this might be right for
Type 1 Diabetes Mellitus
Merck Sharp & Dohme LLC 74
Early research (Phase 1)Study completedNCT02106585
What this trial is testing

Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects

Who this might be right for
Diabetes Mellitus
Akros Pharma Inc. 94
Early research (Phase 1)Study completedNCT06493409
What this trial is testing

Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 32
Early research (Phase 1)Study completedNCT07202871
What this trial is testing

How the Body Absorbs LY3537031

Who this might be right for
Healthy
Eli Lilly and Company 47
Early research (Phase 1)Study completedNCT02662712
What this trial is testing

Orally Administered JNJ-56136379 to Evaluate Safety, Tolerability and Pharmacokinetics After Single Ascending Doses and One Multiple Dose Regimen in Healthy Participants (Part I), and After Multiple Dose Regimens in Participants With Chronic Hepatitis B (Part II)

Who this might be right for
HealthyHepatitis, Chronic
Janssen Sciences Ireland UC 87
Early research (Phase 1)Study completedNCT02637037
What this trial is testing

Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects

Who this might be right for
BioequivalenceFixed Dose Combination TabletsHealthy Male and Female Subjects
AstraZeneca 80
Early research (Phase 1)Study completedNCT01951560
What this trial is testing

Evaluate the Safety and Tolerability of Valproic Acid in Healthy Volunteers (Part 1)

Who this might be right for
Shock,Hemorrhagic
Dr. Hasan Alam 59
Early research (Phase 1)Study completedNCT01430910
What this trial is testing

Assess the Levels of Two Antibiotics in the Blood When Given Together and Separately

Who this might be right for
Healthy
Pfizer 43
Early research (Phase 1)Study completedNCT07039045
What this trial is testing

[14C]-LY4065967 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 16
Early research (Phase 1)UnknownNCT06034015
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers

Who this might be right for
Bladder Cancer
Jiangsu Yahong Meditech Co., Ltd aka Asieris 48
Early research (Phase 1)Study completedNCT00729443
What this trial is testing

Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy Volunteers

Who this might be right for
Healthy Volunteers
AstraZeneca 64
Early research (Phase 1)Study completedNCT03782662
What this trial is testing

Learn About the Drug-drug Interactions of Sisunatovir in Healthy Adult Participants

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 82
Very early researchStudy completedNCT06189170
What this trial is testing

Phase I Study to Evaluate KP405 in Healthy and Parkinson's Disease Patients

Who this might be right for
Safety IssuesTolerance
Kariya Pharmaceuticals 88
Early research (Phase 1)Study completedNCT05136053
What this trial is testing

A Study Investigating Lu AG22515 in Healthy Adults

Who this might be right for
Healthy Participants
H. Lundbeck A/S 58
Early research (Phase 1)Study completedNCT07205081
What this trial is testing

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

Who this might be right for
Normal VolunteersAtopic Dermatitis (AD)Atopic Eczema+1 more
Attovia Therapeutics Inc 48
Early research (Phase 1)Study completedNCT05134337
What this trial is testing

Study of the Effects of Itraconazole and Rifampin on LOXO-305 in Healthy Participants

Who this might be right for
Healthy Volunteers
Loxo Oncology, Inc. 27
Early research (Phase 1)Study completedNCT06954428
What this trial is testing

Clinical Trial of Intranasal Delivery of NT-301

Who this might be right for
Tolerability of NT-301 Nasal SprayPharmacokinetics of NT-301 Nasal SpraySafety of NT-301 Nasal Spray+1 more
Nano PharmaSolutions Australia 49
Early research (Phase 1)Study completedNCT07431866
What this trial is testing

A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)

Who this might be right for
Healthy
Merck Sharp & Dohme LLC 41
Next Page